乳腺病灶评估中18F-FDG PET/CT表现与超声BI-RADS分级的correlation:一项多中心研究
该多中心研究回顾性分析206例高代谢乳腺病灶,计算病灶SUVmax与超声BI-RADS分级的相关性,并以组织学诊断或2年随访末证据为标准,比较BI-RADS、SUVmax及两者联合的诊断效能。结果显示BI-RADS 3-4级病灶中,18F-FDG PET/CT特异度优于BI-RADS,可能有助于进一步鉴别诊断。
要点
- BI-RADS 3-4级病灶中,SUVmax最佳临界值2.705时特异度85.7%,高于BI-RADS的51.8%。
- 全部206例病灶中,BI-RADS/SUVmax联合的AUC为0.977,高于单独BI-RADS的0.948和SUVmax的0.896。
- BI-RADS 3-4级病灶中,联合AUC为0.882,高于单独BI-RADS的0.731和SUVmax的0.859。
核心结论
- 18F-FDG PET/CT与超声BI-RADS分级对乳腺病灶诊断均有效;在BI-RADS 3和4级病灶中,18F-FDG PET/CT特异度更好,可能有助于进一步鉴别诊断。
研究设计与样本
- 多中心回顾性分析,纳入18F-FDG PET/CT与超声均发现高代谢病灶的206例(良性92例、恶性114例),以组织学诊断或2年随访末证据为标准,计算SUVmax与BI-RADS分级的相关性及诊断效能。
关键影像表现/征象
- 病灶SUVmax与BI-RADS分级之间差异有统计学意义(p < 0.001)。
诊断标准与关键数值
- 全部206例病灶中,SUVmax最佳临界值2.325,准确率84.5%、敏感度91.2%、特异度76.1%、PPV 82.5%、NPV 87.5%;BI-RADS对应值分别为85.9%、98.2%、70.7%、80.6%、97.0%。
- 全部206例病灶ROC分析:BI-RADS、SUVmax、BI-RADS/SUVmax联合的AUC分别为0.948、0.896、0.977。
- BI-RADS 3和4级病灶中,SUVmax最佳临界值2.705,准确率82.6%、敏感度77.8%、特异度85.7%、PPV 77.8%、NPV 85.7%;BI-RADS对应值分别为68.5%、94.4%、51.8%、55.7%、93.5%。
- BI-RADS 3-4级病灶ROC分析:BI-RADS、SUVmax、BI-RADS/SUVmax联合的AUC分别为0.731、0.859、0.882。
临床应用与阅片要点
- 作者认为,18F-FDG PET/CT与超声BI-RADS分级对乳腺病灶诊断均有效。
- 作者认为,在BI-RADS 3和4级病灶中,18F-FDG PET/CT特异度更好,可能有助于进一步鉴别诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To analyze the correlation between ultrasound breast imaging reporting and data system (BI-RADS) category and fluorodeoxyglucose [18F] (18F-FDG) positron emission tomography/computed tomography (PET/CT) findings and their value in breast lesion diagnosis.
MATERIALS AND METHODS: Cases involving hypermetabolic lesions identified by 18F-FDG PET/CT and ultrasound were retrospectively analyzed. The correlation between the maximum standardized uptake values (SUVmax) of the lesions and the BI-RADS grades was calculated. Histologic diagnosis or evidence at the end of a 2-year follow-up as the standard of truth were analyzed to determine the sensitivity, specificity, positive predictive values (PPV), and negative predictive values (NPV) of the diagnostic methods. Area under the curve (AUC) of BI-RADS, SUVmax, and BI-RADS/SUVmax combined were obtained using receiver-operating characteristic curve (ROC) analysis.
RESULTS: Of 206 cases, 92 were benign and 114 were malignant. The difference between the SUVmax and the BI-RADS grades was statistically significant (p < 0.001). The critical value of the optimal SUVmax was 2.325, and the accuracy, sensitivity, specificity, PPV, and NPV were 84.5%, 91.2%, 76.1%, 82.5%, and 87.5%, respectively. For diagnosis using BI-RADS, these values were 85.9%, 98.2%, 70.7%, 80.6%, and 97.0%, respectively. ROC analysis of 206 breast lesions for distinguishing benign from malignant lesions yielded AUCs of 0.948, 0.896, and 0.977 for BI-RADS, SUVmax, and BI-RADS/SUVmax combined, respectively. The critical value of the optimal SUVmax in grade 3 and 4 lesions (as determined using BI-RADS) was 2.705, and the accuracy, sensitivity, specificity, PPV, and NPV were 82.6%, 77.8%, 85.7%, 77.8%, and 85.7%, respectively. For diagnosis using BI-RADS in cases with grade 3 and 4 lesions, these values were 68.5%, 94.4%, 51.8%, 55.7%, and 93.5%, respectively. In ROC analysis for distinguishing benign from malignant for BI-RADS grade 3-4 lesions, the AUC of BI-RADS, SUVmax, and BI-RADS/SUVmax combined were 0.731, 0.859, and 0.882, respectively.
CONCLUSION: Both 18F-FDG PET/CT and ultrasound-dependent BI-RADS grading are effective for diagnosing breast lesions. However, in cases of BI-RADS grades 3 and 4, 18F-FDG PET/CT has better specificity and may be useful for further differential diagnosis.
引用
- Yu P, Lei J, Xu B, et al. Correlation Between 18F-FDG PET/CT Findings and BI-RADS Assessment Using Ultrasound in the Evaluation of Breast Lesions: A Multicenter Study. Acad Radiol. 2019. PMID: 31311773. doi:10.1016/j.acra.2019.05.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。